Hospital-based evaluation of programs to prevent perinatal hepatitis B virus transmission

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 6, 1996, Pages 593-597

  Yusuf, Hussain R ^a,c,d   Mahoney, Francis J ^b   Shapiro, Craig N ^b   Mast, Eric E ^b   Polish, Louis ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ANTIGEN DETECTION; ARTICLE; FEMALE; HEPATITIS B; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MATERNAL SERUM; PERINATAL INFECTION; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING; UNITED STATES; VIRUS TRANSMISSION;

EID: 0029993319     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170310027005     Document Type: Article

References (12)

1. Shapiro CN, Margolis HS. Impact of hepatitis B virus infection on women and children. Infect Dis Clin North Am. 1992;6:75-96.
2. McMahon BJ, Alward WLM, Hall DB, et al. Acute hepatitis B virus infection: relation of age to clinical expression of the disease and subsequent development of carrier state. J Infect Dis. 1984;151:599-603.
3. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1991;40:1-19.
4. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA. 1985; 253:1740-1745.
5. Dean AG, Dean JA, Coulombier D, et al. Epi Into, Version 6: A Word Processing, Database, and Statistics System for Epidemiology on Microcomputers. Atlanta, Ga: Centers for Disease Control and Prevention; 1994.
6. Holliman F. US Population Estimates, by Age, Sex, Race, and Hispanic Origin: 1980-1991: Current Population Reports P25-1095. Washington, DC: US Dept of Commerce, Bureau of the Census; 1993.
7. Birnbaum JM, Bromberg K. Evaluation of prophylaxis against hepatitis B in a large municipal hospital. Am J Infect Control. 1992;20:172-176.
8. Centers for Disease Control and Prevention. Maternal hepatitis B screening practices - Califomia, Connecticut, Kansas, and United States, 1992-1993. MMWR Morb Mortal Wkly Rep. 1994;43:317-320.
9. Centers for Disease Control. Prevention of perinatal transmission of hepatitis B virus: perinatal screening of all pregnant women for hepatitis B antigen. MMWR Morb Mortal Wkly Rep. 1988;27:341-351.
10. American Academy of Family Physicians. Recommendations for hepatitis B pre-exposure vaccination and post-exposure prophylaxis. Kansas City, Mo: American Academy of Family Physicians; 1992. Reprint no. 529.
11. Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis. 1991;11:84-92.
12. Siverman NS, Darby MJ, Ronkin SL, Wapner RJ. Hepatitis B prevalence in an unregistered prenatal population: implications for neonatal therapy. JAMA 1991; 266:2852-2855.